Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- AI Summary
- About
HSIC 
Henry Schein Inc (HSIC)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/14/2025: HSIC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -19.71% | Avg. Invested days 46 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 01/14/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 8.81B USD | Price to earnings Ratio 28.62 | 1Y Target Price 76.08 |
Price to earnings Ratio 28.62 | 1Y Target Price 76.08 | ||
Volume (30-day avg) 1247006 | Beta 0.87 | 52 Weeks Range 63.67 - 82.63 | Updated Date 01/14/2025 |
52 Weeks Range 63.67 - 82.63 | Updated Date 01/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 2.47 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 2.51% | Operating Margin (TTM) 6.55% |
Management Effectiveness
Return on Assets (TTM) 3.88% | Return on Equity (TTM) 6.33% |
Valuation
Trailing PE 28.62 | Forward PE 13.83 | Enterprise Value 11680967485 | Price to Sales(TTM) 0.71 |
Enterprise Value 11680967485 | Price to Sales(TTM) 0.71 | ||
Enterprise Value to Revenue 0.93 | Enterprise Value to EBITDA 14.33 | Shares Outstanding 124681000 | Shares Floating 122970667 |
Shares Outstanding 124681000 | Shares Floating 122970667 | ||
Percent Insiders 0.9 | Percent Institutions 107.46 |
AI Summary
Henry Schein Inc. Stock Overview
Company Profile:
History and Background:
- Founded in 1932 as a dental supply company.
- Went public in 1995.
- Today, Henry Schein Inc. (HSIC) is a global leader in the distribution of healthcare products and services.
Core Business Areas:
- Distribution of dental, medical, and veterinary supplies.
- Practice management software and technology solutions.
- Value-added services, such as equipment leasing and financing.
Leadership Team:
- Stanley Bergman: Chairman of the Board and CEO.
- David S. Perlmutter: President and COO.
- Steven K. Paladino: Executive Vice President and CFO.
Corporate Structure:
- Headquartered in Melville, New York.
- Operates in over 30 countries.
Top Products and Market Share:
Top Products:
- Henry Schein Brand: Consumables and dental equipment.
- Arclin: Practice management software.
- DentiMax: Cloud-based dental practice management software.
Market Share:
- Holds the largest market share in the dental supplies industry in the US.
- Significant market presence in the global medical and veterinary supplies markets.
Comparison with Competitors:
- Competitive Advantages: Strong distribution network, broad product portfolio, and value-added services.
- Competitive Disadvantages: Lower margins compared to some competitors.
Total Addressable Market:
- Global healthcare market is estimated to be worth over $8 trillion.
- Dental market alone is worth over $250 billion.
Financial Performance:
Recent Financial Statements:
- Revenue: $15.6 billion (2022)
- Net Income: $556 million (2022)
- Profit Margin: 3.6% (2022)
- EPS: $4.63 (2022)
Year-over-Year Performance:
- Revenue growth has been relatively flat in recent years.
- Profitability has improved slightly.
Cash Flow and Balance Sheet:
- Strong cash flow from operations.
- Manageable debt levels.
Dividends and Shareholder Returns:
Dividend History:
- Pays a quarterly dividend.
- Current dividend yield is approximately 1.5%.
Shareholder Returns:
- Total shareholder return has been around 10% over the past year.
Growth Trajectory:
Historical Growth:
- Revenue has grown at a low single-digit rate over the past 5 years.
- Profitability has improved slightly.
Future Growth Projections:
- Growth is expected to be driven by acquisitions and expansion into new markets.
Market Dynamics:
Industry Trends:
- Growing demand for healthcare services.
- Technological advancements in the healthcare industry.
- Consolidation in the healthcare distribution industry.
Competitive Landscape:
- Henry Schein faces competition from other major healthcare distributors, such as McKesson and Cardinal Health.
Recent Acquisitions:
- 2021: Dentrix, a leading dental practice management software provider.
- 2021: GlobalVet Link, a provider of cloud-based veterinary practice management software.
- 2023: Henry Schein One, a cloud-based platform for healthcare professionals.
AI-Based Fundamental Rating:
Rating: 7.5 out of 10
Justification:
- Strong market position.
- Diversified business model.
- Good financial health.
- Future growth potential.
Sources:
- Henry Schein Inc. Investor Relations website
- SEC filings
- Industry reports
Disclaimers:
This information is for educational purposes only and should not be considered investment advice. Please consult with a licensed financial advisor before making any investment decisions.
Note: This overview incorporates information available as of November 2023. The stock market and company's financial situation may have changed since then.
About NVIDIA Corporation
Exchange NASDAQ | Headquaters Melville, NY, United States | ||
IPO Launch date 1995-11-03 | Executive Chairman & CEO Mr. Stanley M. Bergman CPA | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 26000 | Website https://www.henryschein.com |
Full time employees 26000 | Website https://www.henryschein.com | ||
Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.